JRPGs have been innovating since their conception, and some titles have brought much creativity to their turn-based combat system.
Well, it’s Deino Community Day… again! And that means it’s time to revisit HYDREIGON with Brutal Swing in PvP! Still relevant ...
Apogee Therapeutics has published phase 2 eczema data that suggest its anti-IL-13 antibody is a threat to Eli Lilly, Regeneron and Sanofi, prompting analysts to double their peak sales forecast to ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with potential for best-in-class profiles in the largest inflammatory and ...
Dragon Quest VII? Why? That was the question when I heard about this remake. Square Enix had successfully made HD-2D ports of Dragon Quest III, and a combined package for I-II. It seemed intent on ...
Apogee Therapeutics (APGE) leverages IL-13 pathway optimization to enable less frequent dosing, targeting a leadership shift in biologic treatment for inflammatory diseases. APGE's $913 million cash ...
Donald Nolan, CEO & Executive Chairman of the Board, began the call by announcing a leadership transition: "Matt Osberg has informed us of his decision to leave the company to pursue an opportunity ...
Apogee missed on Q2 sales this morning, and warned of an earnings miss this year. Apogee stock pays a nice dividend and costs less than 10x this year's earnings. Heading into the report, analysts ...
MINNEAPOLIS--(BUSINESS WIRE)--Apogee Enterprises, Inc. (Nasdaq: APOG) announced today the resignation of Matthew J. Osberg as Chief Financial Officer. Mr. Osberg is leaving Apogee to pursue another ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The board will immediately begin ...
With the HD remake, Square Enix has done more than upgrade the visuals. New mechanics, gameplay content, accessibility features, and more await in this HD bundle of the series’ first two games. Though ...